ProCE Banner Activity

Interactive Decision Support Tool: Expert Insights on Therapy for Locally Advanced or Metastatic Bladder Cancer

Tool

This Interactive Decision Support Tool will let you compare your choice of therapy for patients with advanced bladder cancer with expert recommendations from Matthew Galsky, MD; Shilpa Gupta, MD; Matthew I. Milowsky, MD; Elizabeth R. Plimack, MD, MS; and Arlene O. Siefker-Radtke, MD.

Released: July 19, 2021

Expiration: July 18, 2022

No longer available for credit.

Share

Faculty

Matthew Galsky

Matthew Galsky, MD

Professor of Medicine
Director of Genitourinary Medical Oncology
Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, New York

Shilpa Gupta

Shilpa Gupta, MD

Clinical Professor of Medicine
Case Western Reserve University
Director, Genitourinary Oncology
Cleveland Clinic Taussig Cancer Institute
Cleveland, Ohio

Matthew I. Milowsky

Matthew I. Milowsky, MD

Professor of Medicine
Division of Hematology/Oncology
Department of Medicine
Lineberger Comprehensive Cancer Center
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Elizabeth Plimack

Elizabeth Plimack, MD, MS

Assistant Professor
Associate Member
Medical Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

Arlene O. Siefker-Radtke

Arlene O. Siefker-Radtke, MD

Professor
Genitourinary Medical Oncology
University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Bristol Myers Squibb

Pfizer and EMD Serono

Additional Information

Program Medium

This program has been made available online.